TCL Announces Winter Sports Athletes Joining Team TCL, Embodying the Spirit of "Inspire Greatness"
100-Day Countdown to Olympic Winter Games Milano Cortina 2026 kicks off as TCL Encourages People to Share "Wishes for Greatness" SHENZHEN, China, Oct. 29, 2025 /PRNewswire/ -- TCL, a global technology company, today announced that Team TCL has now...
SK hynix Announces 3Q25 Financial Results
- Reports revenues of 24.4489 trillion won, operating profit of 11.3834 trillion won, net profit of 12.5975 trillion won - Record-high quarterly performance driven by strong sales of HBM and high-performance server products - HBM supply discussion...
WEKA Announces New NeuralMesh Architecture Built for NVIDIA BlueField-4
Revolutionary Platform Design Marks Major Evolution in AI Infrastructure, Eliminating Traditional CPU Requirements While Delivering Breakthrough Performance Density, Linear Scalability and Exceptional Power Efficiency for Enterprise AI Factories...
Charming Medical Limited Announces Full Exercise of Representative's Over-allotment Option
HONG KONG, Oct. 29, 2025 /PRNewswire/ -- Charming Medical Limited (Nasdaq: MCTA) (the "Company") , a Hong Kong-based provider of Traditional Chinese Medicine (TCM)-inspired therapies and products , today announced, in connection with its previously...
Fosun Pharma Announces 2025Q3 Financial Results
Innovative Achievements Continue to Come to Fruition, Revenue from Innovative Drugs Exceeding RMB6,700 Million in The First Three Quarters of 2025 SHANGHAI, Oct. 28, 2025 /PRNewswire/ -- On October 28, 2025, Shanghai Fosun Pharmaceutical (Group)...
MMTEC, Inc. Announces Receipt of Nasdaq Delisting Determination Regarding Minimum Bid Price Deficiency
HONG KONG, Oct. 28, 2025 /PRNewswire/ -- MMTEC, Inc. (NASDAQ: MTC) ("MMTEC", "we", "our" or the "Company"), a China-based technology company that provides access to the U.S. financial markets, today announced that on October 27, 2025, the Company...
Myrio Therapeutics Announces Collaboration with Leading Research Institutions to Advance Solid Tumor T cell Immunotherapeutics
Myrio Therapeutics, the University of Pennsylvania Perelman School of Medicine, and NYU Langone Health have entered a research collaboration to accelerate the development of next-generation T cell immunotherapies Partnership with T cell experts...
China Yuchai Announces Board Change
SINGAPORE, Oct. 28, 2025 /PRNewswire/ -- China Yuchai International Limited (NYSE: CYD) ("China Yuchai" or the "Company") announced today that Mr. Wu Qiwei has resigned as a Director of the Company with effect from October 27, 2025. Mr. Wu has also...
New Oriental Announces Results for the First Fiscal Quarter Ended August 31, 2025
BEIJING, Oct. 28, 2025 /PRNewswire/ -- New Oriental Education & Technology Group Inc. (the "Company" or "New Oriental") (NYSE: EDU/ 9901.SEHK), a provider of private educational services in China, today announced its unaudited financial results...
LUMOSA THERAPEUTICS ANNOUNCES POSITIVE RESULTS FROM LT3001(INTRAVENOUS ODATROLTIDE) PHASE 2B CLINICAL TRIAL IN ACUTE ISCHEMIC STROKE
Results presented at the 17th World Stroke Congress (WSC 2025) LT3001(Odatroltide)-202 phase 2b study met primary endpoint. No symptomatic intracranial hemorrhage occurred. Data suggest that LT3001 has the potential to provide significant clinical...